Curis Inc. (CRIS) has disclosed a new risk, in the Corporate Activity and Growth category.
Curis Inc. has disclosed that throughout the first quarter of 2024, no directors or officers engaged in establishing or concluding any contracts or plans for trading the company’s securities that would adhere to Rule 10b5-1(c) under the Exchange Act. This absence of new trading plans, which might indicate an insider’s confidence in the company’s future, can also be perceived as a lack of proactive financial management. In addition, the absence of ‘non-Rule 10b5-1 trading arrangements’ might suggest that the company’s insiders are not actively managing their holdings in Curis Inc., potentially leading to concerns about their commitment to the company’s long-term success.
The average CRIS stock price target is $26.50, implying 63.58% upside potential.
To learn more about Curis Inc.’s risk factors, click here.
